Financial Comparison: Central Puerto (NYSE:CEPU) & Biotricity (OTCMKTS:BTCY)

Central Puerto (NYSE:CEPUGet Rating) and Biotricity (OTCMKTS:BTCYGet Rating) are both small-cap oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Profitability

This table compares Central Puerto and Biotricity’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Central Puerto 16.67% 7.33% 4.68%
Biotricity N/A N/A N/A

Institutional and Insider Ownership

2.6% of Central Puerto shares are owned by institutional investors. Comparatively, 5.1% of Biotricity shares are owned by institutional investors. 0.1% of Central Puerto shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility and Risk

Central Puerto has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

Earnings and Valuation

This table compares Central Puerto and Biotricity’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Central Puerto $600.19 million 1.10 -$7.79 million $0.66 6.67
Biotricity $7.70 million 6.05 -$32.70 million ($0.63) -1.42

Central Puerto has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Central Puerto, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Central Puerto and Biotricity, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Central Puerto 0 0 0 0 N/A
Biotricity 0 1 2 0 2.67

Biotricity has a consensus price target of $5.67, indicating a potential upside of 531.59%. Given Biotricity’s higher possible upside, analysts plainly believe Biotricity is more favorable than Central Puerto.

Summary

Central Puerto beats Biotricity on 7 of the 12 factors compared between the two stocks.

About Central Puerto

(Get Rating)

Central Puerto S.A. generates and sells electric power to private and public customers in Argentina. It also produces steam. As of December 31, 2021, the company owned and operated five thermal generation plants, one hydroelectric generation plant, and seven wind farms with a total installed capacity of 4,809 MW. Central Puerto S.A. was founded in 1898 and is based in Buenos Aires, Argentina.

About Biotricity

(Get Rating)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive News & Ratings for Central Puerto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Puerto and related companies with MarketBeat.com's FREE daily email newsletter.